• Citer

Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide-refractory multiple myeloma: Intergroupe Francophone du Myélome 2009-02.

par Leleu, Xavier;Attal, Michel;Arnulf, Bertrand;Moreau, Philippe;Traulle, Catherine;Marit, Gerald;Mathiot, Claire;Petillon, Marie Odile;Macro, Margaret;Roussel, Murielle;Pegourie, Brigitte;Kolb, Brigitte;Stoppa, Anne Marie;Hennache, Bernadette;Bréchignac, Sabine;Meuleman, Nathalie ;Thielemans, Beatrice;Garderet, Laurent;Royer, Bruno;Hulin, Cyrille;Benboubker, Lotfi;Decaux, Olivier;Escoffre-Barbe, M.;Michallet, Mauricette;Caillot, Denis;Fermand, Jean-Paul;Avet-Loiseau, Herve;Facon, Thierry;Intergroupe Francophone du Myélome,
Référence Blood, 121, 11, page (1968-1975)
Publication Publié, 2013-03

Article révisé par les pairs

• Détails
• Contenu

Titre:	Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide-refractory multiple myeloma: Intergroupe Francophone du Myélome 2009-02.
Auteur:	Leleu, Xavier; Attal, Michel; Arnulf, Bertrand; Moreau, Philippe; Traulle, Catherine; Marit, Gerald; Mathiot, Claire; Petillon, Marie Odile; Macro, Margaret; Roussel, Murielle; Pegourie, Brigitte; Kolb, Brigitte; Stoppa, Anne Marie; Hennache, Bernadette; Bréchignac, Sabine; Meuleman, Nathalie; Thielemans, Beatrice; Garderet, Laurent; Royer, Bruno; Hulin, Cyrille; Benboubker, Lotfi; Decaux, Olivier; Escoffre-Barbe, M.; Michallet, Mauricette; Caillot, Denis; Fermand, Jean-Paul; Avet-Loiseau, Herve; Facon, Thierry; Intergroupe Francophone du Myélome,
Informations sur la publication:	Blood, 121, 11, page (1968-1975)
Statut de publication:	Publié, 2013-03
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Adult
	Aged
	Aged, 80 and over
	Antineoplastic Combined Chemotherapy Protocols -- adverse effects -- therapeutic use
	Boronic Acids -- administration & dosage
	Dexamethasone -- administration & dosage -- adverse effects
	Dose-Response Relationship, Drug
	Drug Resistance, Neoplasm -- drug effects
	France
	Humans
	Medical Oncology -- organization & administration
	Middle Aged
	Multiple Myeloma -- drug therapy
	Pyrazines -- administration & dosage
	Societies, Medical
	Thalidomide -- administration & dosage -- adverse effects -- analogs & derivatives
	Treatment Failure
	Treatment Outcome
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0006-4971
	info:doi/10.1182/blood-2012-09-452375
	info:pii/blood-2012-09-452375
	info:scp/84877622448
	info:pmid/23319574